title: Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease.
abstract: To investigate whether an imbalance exists in the production between angiogenic and antiangiogenic growth factors in patients with Kawasaki disease (KD), we measured the serum levels of vascular endothelial growth factor (VEGF) and endostatin (ES) in 35 patients with KD, 15 patients with acute febrile diseases (disease controls) and 15 healthy children. KD patients had significantly higher VEGF levels and lower ES levels (P < 0.01) in the acute and subacute phases than the disease control and healthy children. KD patients with coronary artery lesions (CAL, n = 10) had significantly higher VEGF levels and lower ES levels (P < 0.05) in the subacute and convalescent phases than those without CAL (n = 25). The ratios of VEGF/ES in sera of KD patients with CAL were significantly higher (P < 0.05) in the acute and convalescent phases compared to those without CAL. Furthermore, the occurrence of CAL significantly correlated with the VEGF/ES ratio above 10 x 10(-3) in the subacute phase of KD (Odds ratio 17.25, P = 0.005). The findings in the present study indicate that an imbalance exists in the production between VEGF and ES in patients with KD while also suggesting that KD patients with a high VEGF/ES ratio have a significantly greater risk of CAL involvement.
authors.affiliation: University of Shizuoka, Junior college, Shizuoka, Japan. takesita@bambi.t.u-shizuoka-ken.ac.jp
authors.forename: S
authors.initials: S
authors.lastname: Takeshita
authors.forename: Y
authors.initials: Y
authors.lastname: Kawamura
authors.forename: H
authors.initials: H
authors.lastname: Takabayashi
authors.forename: N
authors.initials: N
authors.lastname: Yoshida
authors.forename: S
authors.initials: S
authors.lastname: Nonoyama
mesh_terms: D000208:Acute Disease; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D003327:Coronary Disease / Q000097:blood / Q000000981:diagnostic imaging; D004452:Echocardiography; D043169:Endostatins / Q000097:blood*; D005260:Female; D005334:Fever / Q000097:blood; D006801:Humans; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000097:blood* / Q000000981:diagnostic imaging; D012306:Risk; D018709:Statistics, Nonparametric; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
chemical_list: D043169:Endostatins; D042461:Vascular Endothelial Growth Factor A
references.citation: Circulation. 2000 Jun 27;101(25):2935-41
references.pmid: 10869266
references.citation: EMBO J. 1999 Aug 16;18(16):4414-23
references.pmid: 10449407
references.citation: Pediatr Res. 2001 Jan;49(1):74-80
references.pmid: 11134495
references.citation: Cancer. 2001 Apr 15;91(8):1525-9
references.pmid: 11301401
references.citation: Circulation. 2002 Feb 12;105(6):766-9
references.pmid: 11839635
references.citation: Eur J Pediatr. 2002 Feb;161(2):105-11
references.pmid: 11954744
references.citation: Cancer. 2002 Oct 15;95(8):1637-43
references.pmid: 12365010
references.citation: Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1042-7
references.pmid: 12601027
references.citation: Clin Exp Immunol. 2003 Mar;131(3):536-40
references.pmid: 12605708
references.citation: FEBS Lett. 2003 Mar 27;539(1-3):149-55
references.pmid: 12650943
references.citation: Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):576-81
references.pmid: 12692003
references.citation: Cancer. 2003 Jun 1;97(11):2767-75
references.pmid: 12767089
references.citation: Mediators Inflamm. 2003 Jun;12(3):167-71
references.pmid: 12857600
references.citation: Cancer Lett. 2004 Feb 10;204(1):87-95
references.pmid: 14744538
references.citation: Clin Sci (Lond). 2004 May;106(5):439-42
references.pmid: 14965340
references.citation: J Am Coll Cardiol. 2004 Apr 21;43(8):1383-7
references.pmid: 15093871
references.citation: Pediatrics. 1974 Sep;54(3):271-6
references.pmid: 4153258
references.citation: J Pediatr. 1975 Jun;86(6):892-8
references.pmid: 236368
references.citation: Eur J Pediatr. 1978 Aug 17;129(1):17-27
references.pmid: 679953
references.citation: J Exp Med. 1986 Dec 1;164(6):1958-72
references.pmid: 3491174
references.citation: Science. 1989 Dec 8;246(4935):1306-9
references.pmid: 2479986
references.citation: Lancet. 1989 Dec 2;2(8675):1298-302
references.pmid: 2480498
references.citation: Mol Biol Cell. 1992 Feb;3(2):211-20
references.pmid: 1550962
references.citation: Cell. 1997 Jan 24;88(2):277-85
references.pmid: 9008168
references.citation: Blood. 1998 May 15;91(10):3527-61
references.pmid: 9572988
references.citation: FASEB J. 1999 Jan;13(1):9-22
references.pmid: 9872925
references.citation: Am J Cardiol. 1999 Feb 1;83(3):337-9
references.pmid: 10072219
references.citation: J Biol Chem. 1999 Apr 23;274(17):11721-6
references.pmid: 10206987
references.citation: EMBO J. 1999 Jul 15;18(14):3964-72
references.pmid: 10406801
references.citation: J Rheumatol. 2000 Oct;27(10):2339-42
references.pmid: 11036826